Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials
-
AstraZeneca agrees to divest Viela shareholding
-
COVID-19 Vaccine AstraZeneca authorised for use in the EU
-
COVID-19 Vaccine AstraZeneca recommended for use in the EU
-
Tagrisso extended disease-free survival regardless of prior adjuvant chemotherapy in early-stage EGFR-mutated lung cancer
-
Datopotamab deruxtecan and Enhertu show promising early clinical activity in patients with advanced non-small cell lung cancer
-
Symbicort Turbuhaler approved in China as an anti-inflammatory reliever in mild asthma
-
Calquence approved in Japan for the treatment of relapsed or refractory chronic lymphocytic leukaemia
-
Calquence met primary efficacy endpoint in head-to-head trial against ibrutinib in chronic lymphocytic leukaemia
-
Enhertu approved in the EU for the treatment of HER2-positive metastatic breast cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
